Cargando…
Fair Allocation of Scarce Therapies for Coronavirus Disease 2019 (COVID-19)
The US Food and Drug Administration (FDA) has issued emergency use authorizations (EUAs) for monoclonal antibodies (mAbs) for nonhospitalized patients with mild or moderate coronavirus disease 2019 (COVID-19) disease and for individuals exposed to COVID-19 as postexposure prophylaxis. EUAs for oral...
Autores principales: | Persad, Govind, Peek, Monica E, Shah, Seema K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807190/ https://www.ncbi.nlm.nih.gov/pubmed/34922352 http://dx.doi.org/10.1093/cid/ciab1039 |
Ejemplares similares
-
Fair domestic allocation of monkeypox virus countermeasures
por: Persad, Govind, et al.
Publicado: (2023) -
Fair and diverse allocation of scarce resources
por: Anahideh, Hadis, et al.
Publicado: (2022) -
The shared ethical framework to allocate scarce medical resources: a lesson from COVID-19
por: Emanuel, Ezekiel J, et al.
Publicado: (2023) -
Allocating scarce intensive care resources during the COVID-19 pandemic: practical challenges to theoretical frameworks
por: Supady, Alexander, et al.
Publicado: (2021) -
Categorized Priority Systems: A New Tool for Fairly Allocating Scarce Medical Resources in the Face of Profound Social Inequities
por: Sönmez, Tayfun, et al.
Publicado: (2021)